Our CEO is currently in Granada, Spain, where he has been kindly invited to visit the prestigious Medina Foundation, a renowned non-profit research center born in collaboration with the University of Granada. This opportunity presents a unique occasion to explore the frontiers of scientific research in the field of cancer metabolomics. In the afternoon, our CEO will deliver a significant presentation at the VII Reunion Metabolomica y Cancer. This conference, dedicated to discussing the major horizons of metabolomics in the oncological context, will focus on integrating metabolomics with other liquid biopsy techniques, analyzing the most significant technical and methodological advancements. Furthermore, it will delve into the utility of data mining and bioinformatics in oncology, providing a comprehensive overview of future prospects and challenges in this crucial field of medical research.